A detailed history of Hc Advisors, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Hc Advisors, LLC holds 1,479 shares of ASND stock, worth $198,452. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,479
Holding current value
$198,452
% of portfolio
0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$123.45 - $159.4 $182,582 - $235,752
1,479 New
1,479 $223,000
Q4 2022

Feb 08, 2023

SELL
$99.42 - $131.97 $49,710 - $65,985
-500 Reduced 19.42%
2,075 $253,000
Q3 2022

Nov 10, 2022

SELL
$84.03 - $110.23 $5,966 - $7,826
-71 Reduced 2.68%
2,575 $266,000
Q2 2022

Aug 08, 2022

BUY
$78.08 - $117.61 $156 - $235
2 Added 0.08%
2,646 $246,000
Q1 2022

May 06, 2022

SELL
$102.18 - $135.75 $29,836 - $39,639
-292 Reduced 9.95%
2,644 $310,000
Q4 2021

Feb 02, 2022

BUY
$127.1 - $169.66 $71,811 - $95,857
565 Added 23.83%
2,936 $395,000
Q3 2021

Oct 29, 2021

SELL
$112.67 - $176.92 $9,464 - $14,861
-84 Reduced 3.42%
2,371 $378,000
Q2 2021

Aug 09, 2021

SELL
$121.62 - $145.29 $11,189 - $13,366
-92 Reduced 3.61%
2,455 $323,000
Q1 2021

May 07, 2021

BUY
$124.92 - $173.33 $6,246 - $8,666
50 Added 2.0%
2,547 $328,000
Q4 2020

Feb 08, 2021

BUY
$151.2 - $182.76 $29,030 - $35,089
192 Added 8.33%
2,497 $416,000
Q3 2020

Nov 04, 2020

BUY
$134.29 - $154.32 $34,646 - $39,814
258 Added 12.6%
2,305 $356,000
Q2 2020

Aug 12, 2020

BUY
$110.87 - $156.01 $226,950 - $319,352
2,047 New
2,047 $303,000

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.49B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Hc Advisors, LLC Portfolio

Follow Hc Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hc Advisors, LLC with notifications on news.